Open an account

LifeVantage

LFVN · NASDAQ

$5.97−$0.01 (−0.17%)TodayMarket closed ·
Prev close $5.98

About LFVN

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

Employees
232
Headquarters
Lehi, Utah
Listed
Sep 12, 2012
Sector
Consumer Staples
Industry
Personal Care Products
Website
lifevantage.com

LFVN key statistics

Market cap
75.16M
Price-earnings ratio
14.95
Dividend yield
3.11%
Average volume
31.99K
Volume
22.81K
Open price
$5.98
High today
$6.11
Low today
$5.93
52 Week high
$11.71
52 Week low
$3.90

LifeVantage (LFVN) at a glance

As of Oct 20, 2026, LifeVantage (LFVN) shares are priced at $5.97, giving the company a market cap of 75.16M, a price-to-earnings ratio of 14.95 and a dividend yield of 3.11%.

Today the stock has traded between $5.93 and $6.11. The current price is 0.6% above the day's low and 2.3% below its high.

Volume so far is 22.81K shares, below the average of 31.99K shares a day.

Over the past year LifeVantage has ranged from $3.90 to $11.71, and now sits 27% of the way up that range.

LifeVantage met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q4 FY26 it reported $0.11 per share against an estimate of $0.1292.

The average analyst price target is $7.65, 28.1% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 4 analystsAvg $7.65
Low
$6.06
Now
$5.97
High
$9.45

LFVN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 58.9% on average.

  1. Q1 FY25: reported $0.15 per share against an estimate of $0.153
  2. Q2 FY25: reported $0.22 per share against an estimate of $0.136
  3. Q3 FY25: reported $0.26 per share against an estimate of $0.1666
  4. Q4 FY25: reported $0.15 per share against an estimate of $0.1581
  5. Q1 FY26: reported $0.18 per share against an estimate of $0.1887
  6. Q2 FY26: reported $0.15 per share against an estimate of $0.153
  7. Q3 FY26: reported $0.12 per share against an estimate of $0.1598
  8. Q4 FY26: reported $0.11 per share against an estimate of $0.1292

LFVN news

  • Mohd Haider

    Why Did LifeVantage (LFVN) Stock Jump 27% After Hours?

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the Sidoti Small Cap Conference

  • Press releaseGlobe Newswire

    LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the 28th Annual ICR Conference

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the LD Micro Main Event XIX on October 20, 2025

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

  • Avi Kapoor

    American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • Avi Kapoor

    Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as LifeVantage

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.